.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Effective Epilepsy Medication Monitoring is essential for patient safety. Therefore, the All India Institute of Medical Sciences (AIIMS) in New Delhi has introduced a specialized facility for monitoring anti-epilepsy drug levels. Specifically, the service tracks levetiracetam and lamotrigine in the blood. Doctors explain that the same dose affects patients differently due to unique metabolic rates. Consequently, inaccurate drug levels can lead to seizure recurrence or medication toxicity.
Personalizing treatment through monitoring offers several advantages for clinicians and patients alike. First, it ensures that drug concentrations remain within the therapeutic window. Second, it helps identify toxicity risks before they cause severe side effects. Furthermore, the test detects cases where medicines fail to reach effective levels despite regular intake. Because private laboratories charge between Rs 6,000 and Rs 10,000 per drug, this low-cost initiative significantly improves access to precision-based care.
The new facility is located at the AIIMS Neurosciences Centre and extends services to the NCI-AIIMS Jhajjar campus. Currently, patients can access these tests free of cost, though subsidized rates may apply later. Additionally, results are available online through the e-Hospital and ORS portals. This digital integration ensures that both outpatient and admitted patients receive timely data. Moreover, advanced neurodiagnostic facilities like these help manage complex neurological disorders more effectively.
Q1: Which specific medications does the new AIIMS TDM facility monitor?
The facility currently monitors levels of two common anti-epilepsy drugs, levetiracetam and lamotrigine, to ensure they are at safe and effective levels.
Q2: How much do these TDM tests cost at AIIMS?
The tests are currently provided free of charge at AIIMS. However, the institute may introduce highly subsidized rates in the future as per their policy.
Q3: Is the monitoring service available for both outpatients and admitted patients?
Yes, the facility serves both outpatients (OPD) and admitted patients at AIIMS New Delhi and the NCI-AIIMS Jhajjar campus.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
AIIMS New Delhi has introduced a low-cost Therapeutic Drug Monitoring service for epilepsy drugs to personalize dosages and minimize medication side effects...
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
